Specific tolerance to neural allografts induced with an antibody to the interleukin 2 receptor.

Specific tolerance to neural allografts induced with an antibody to the interleukin 2 receptor.

Despite considerable evidence documenting the central nervous system as a site of immunological privilege, immune responses do occur within the brain and neural allografts between major histocompatibility complexes (MHC) and minor antigen incompatible rat strains may be rejected. The survival of com...

Bibliografske podrobnosti
Main Authors:	Wood, M, Sloan, D, Dallman, M, Charlton, H
Format:	Journal article
Jezik:	English
Izdano:	1993

Podobne knjige/članki

A monoclonal antibody to the interleukin-2 receptor enhances the survival of neural allografts: a time-course study.
od: Wood, M, et al.
Izdano: (1992)

Indefinite survival of neural xenografts induced with anti-CD4 monoclonal antibodies.
od: Wood, M, et al.
Izdano: (1996)

Induction of oral tolerance and the effect of interleukin-4 on murine skin allograft rejection
od: A.L.A. Dettino, et al.
Izdano: (2004-03-01)

Cytokines and peripheral tolerance to alloantigen.
od: Dallman, M, et al.
Izdano: (1993)

Cytokines and peripheral tolerance to alloantigen
od: Dallman, M, et al.
Izdano: (1993)

B7-H4 Induces Donor-Specific Tolerance in Mouse Islet Allografts
od: Xiaojie Wang, et al.
Izdano: (2012-02-01)

CD4 and CD8 monoclonal antibody therapy in the dog: strategies to induce tolerance to renal allografts.
od: Watson, C, et al.
Izdano: (1995)

The immune response to intracerebral neural grafts.
od: Sloan, D, et al.
Izdano: (1991)

CCL22 Prevents Rejection of Mouse Islet Allografts and Induces Donor-Specific Tolerance
od: Joel Montane, et al.
Izdano: (2015-10-01)

Low dose interleukin-2 selectively expands circulating regulatory T cells but fails to promote liver allograft tolerance in humans
od: Lim, TY, et al.
Izdano: (2022)

Nondepleting anti-CD4 monoclonal antibody enhances the ability of oral alloantigen delivery to induce indefinite survival of cardiac allografts: oral tolerance to alloantigen.
od: Niimi, M, et al.
Izdano: (2000)

Tolerability of Sarilumab – An anti-interleukin-6 receptor monoclonal antibody is controversial for the management of COVID-19
od: Justin Jacob Abraham, et al.
Izdano: (2021-01-01)

The intragraft vascularized bone marrow induces secondary donor-specific mystacial pad allograft tolerance
od: Cheng-Hung Lin, et al.
Izdano: (2022-12-01)

Delayed allograft rejection in primates treated with anti-IL-2 receptor monoclonal antibody Campath-6.
od: Tighe, H, et al.
Izdano: (1988)

Early infiltration of allografts by a subset of host mononuclear cells bearing inhibitory Ly49 receptors determines development of allograft rejection or tolerance.
od: Ozkaynak, E, et al.
Izdano: (2005)

Induction of Immunological Tolerance to Islet Allografts
od: Aldo A. Rossini M.D., et al.
Izdano: (1996-01-01)

Identification of regulatory T cells in tolerated allografts.
od: Graca, L, et al.
Izdano: (2002)

Pretransplant blood transfusion with additional immunotherapy tolerizes recipients to islet allografts
od: Bortecen, K, et al.
Izdano: (2005)

Beneficial effect of monoclonal antibody to interleukin 2 receptor on activated T cells in rheumatoid arthritis.
od: Kyle, V, et al.
Izdano: (1989)

Relationship between Serum Soluble Interleukin-2 Receptor and Renal Allograft Rejection: A Hospital-Based Study in Kashmir Valley
od: R Rasool, et al.
Izdano: (2015-01-01)

Interleukin 21 (IL-21) regulates chronic allograft vasculopathy (CAV) in murine heart allograft rejection.
od: Mithun Khattar, et al.
Izdano: (2019-01-01)

Hematopoietic chimerism and donor-specific skin allograft tolerance after non-genotoxic CD117 antibody-drug-conjugate conditioning in MHC-mismatched allotransplantation
od: Zhanzhuo Li, et al.
Izdano: (2019-02-01)

Donor-Specific Antibodies in the Absence of Rejection Are Not a Risk Factor for Allograft Failure
od: Sandesh Parajuli, et al.
Izdano: (2019-08-01)

Th17: contributors to allograft rejection and a barrier to the induction of transplantation tolerance?
od: Chadha, R, et al.
Izdano: (2011)

Anti-Interleukin-6 Receptor Antibody Therapy-Induced Retinopathy in a Patient with Rheumatoid Arthritis
od: Asumi Tada, et al.
Izdano: (2012-01-01)

SARS-CoV-2 Spike Protein-Induced Interleukin 6 Signaling Is Blocked by a Plant-Produced Anti-Interleukin 6 Receptor Monoclonal Antibody
od: Collin Jugler, et al.
Izdano: (2021-11-01)

Research Note: Development and characterization of monoclonal antibodies specific for chicken interleukin-7 receptor α (CD127)
od: Zhifeng Sun, et al.
Izdano: (2022-10-01)

The thymus is essential for the development of operational tolerance induced by donor-specific transfusion plus anti-CD4 monoclonal antibody.
od: Niimi, M, et al.
Izdano: (2000)

Flt3L combined with rapamycin promotes cardiac allograft tolerance by inducing regulatory dendritic cells and allograft autophagy in mice.
od: Ali Xiong, et al.
Izdano: (2012-01-01)

Heart Allograft Tolerance Induced and Maintained by Vascularized Hind-Limb Transplant in Rats
od: Quan Liu, et al.
Izdano: (2013-01-01)

Targeting Metabolism as a Platform for Inducing Allograft Tolerance in the Absence of Long-Term Immunosuppression
od: Chih-Hsien Cheng, et al.
Izdano: (2020-04-01)

Alpha-1,2-mannosidase and hence N-glycosylation are required for regulatory T cell migration and allograft tolerance in mice.
od: Long, E, et al.
Izdano: (2010)

Use of Anti-Interleukin-6 Receptor Monoclonal Antibody in Drug-Induced Acute Respiratory Distress Syndrome
od: Alessandra Petrillo, et al.
Izdano: (2020-01-01)

Pretransplant Donor-Specific Anti-HLA Antibodies and the Risk for Rejection-Related Graft Failure of Kidney Allografts
od: Michiel G. H. Betjes, et al.
Izdano: (2020-01-01)

Interleukin-2 receptor activation by an anti-IL-2Rβ/γc bispecific antibody
od: Brauer, Peter
Izdano: (2016)

Oral administration of alloantigen plus nondepleting anti-CD4 monoclonal antibody induces indefinite prolongation of fully allogeneic cardiac allografts.
od: Niimi, M, et al.
Izdano: (2000)

Islet allografting in the dog model: potential therapies for tolerance induction.
od: Brons, I, et al.
Izdano: (1995)

Long-term tolerance of islet allografts in nonhuman primates induced by apoptotic donor leukocytes
od: Amar Singh, et al.
Izdano: (2019-08-01)

Engraftment of marrow allografts treated with Campath-1 monoclonal antibodies.
od: Naparstek, E, et al.
Izdano: (1999)

Genetic polymorphisms of Interleukin-18 are not associated with allograft function in kidney transplant recipients
od: Wenna Gleyce Araújo do Nascimento, et al.
Izdano: (2014-06-01)